ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Qihong Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, ATP Citrate (pro-S)-Lyase, Proteasome Endopeptidase Complex. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Wenzhou Science and Technology Project, Province Key Surgery Projects (Zhejiang High-Tech 2008-255, Zhejiang High-Tech 2012-80 and Zhejiang High-Tech 2016-169).
Abstract (Originalsprache)
The search for novel tumor biomarkers and targets is of significant importance for the early clinical diagnosis and treatment of Hepatocellular Carcinoma (HCC). The mechanisms by which ATP citrate lyase (ACLY) promotes HCC progression remain unclear, and the connection between ACLY and REGγ has not been reported in the literature. In vitro, we will perform overexpression/knockdown of ACLY or overexpression/knockdown of REGγ to investigate the impact of ACLY on HCC cells and its underlying mechanisms. In vivo, we will establish mouse tumor models with overexpression/knockdown of ACLY or overexpression/knockdown of REGγ to study the effect of ACLY on mouse tumors and its mechanisms. Firstly, ACLY overexpression upregulated REGγ expression and activated the REGγ‐proteasome pathway, leading to changes in the expression of downstream signaling pathway proteins. This promoted HCC cell proliferation, invasion, and migration in vitro, as well as tumor growth and metastasis in vivo. Secondly, ACLY overexpression increased acetyl‐CoA production, upregulated the acetylation level of the REGγ promoter region histone H3K27ac, and subsequently induced REGγ expression. Lastly, enhanced acetylation of the REGγ promoter region histone H3K27ac resulted in upregulated REGγ expression, activation of the REGγ‐proteasome pathway, changes in downstream signaling pathway protein expression, and promotion of HCC cell proliferation, invasion, and migration in vitro, as well as tumor growth and metastasis in vivo. Conversely, REGγ knockdown reversed these effects. ACLY and REGγ may serve as potential biomarkers and clinical therapeutic targets for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
- Departments of Nursing, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
Förderung
- Wenzhou Science and Technology Project
- Province Key Surgery Projects (Zhejiang High-Tech 2008-255, Zhejiang High-Tech 2012-80 and Zhejiang High-Tech 2016-169)
Zitieren
APA
Cai, Q., Zhu, H., Dai, Y., Zhou, Q., Zhang, Q., & Zhu, Q. (2024). ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23777
Vancouver
Cai Q, Zhu H, Dai Y, Zhou Q, Zhang Q, Zhu Q. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23777
BibTeX
@article{Cai2024,
author = {Cai, Qihong and Zhu, Honghua and Dai, Yile and Zhou, Qingqing and Zhang, Qiyu and Zhu, Qiandong},
title = {ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23777}
}
EUVIMED